Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-04-18
2006-04-18
Spivack, Phyllis G. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
07030108
ABSTRACT:
A method of combating movement disorder is disclosed in a patient with Parkinson's disease comprising administering an effective amount of mirtazapine, a receptor antagonist for 5HT2/3and α2receptors.
REFERENCES:
patent: 3983234 (1976-09-01), Sayers
patent: 4062848 (1977-12-01), van der Burg
patent: 4968692 (1990-11-01), Linnoila et al.
patent: 5198459 (1993-03-01), Imperato et al.
patent: 5216001 (1993-06-01), Perregaard et al.
patent: 5288749 (1994-02-01), Meyer et al.
patent: 5948806 (1999-09-01), Colpaert et al.
patent: 6281207 (2001-08-01), Richter et al.
patent: WO 94/13285 (1994-06-01), None
Henry et al., Experimental Neurology, 151(2), 334-342 (1998) (abstract).
Rawlow et al., European Journal of Pharmacology, 191(3), 263-72 (1990) (abstract).
Davis et al., CNS Drugs, 5/5 (389-402) (1996) (abstract).
Lin-Shiau et al. Chemical Abstracts, vol. 121, Abstract No. 73678, 1994.
Giduz Thomas
Richter Virginia Pact
Hultquist Steven J.
Hultquist Steven J.
Intellectual Property / Technology Law
Reed Richter
Spivack Phyllis G.
LandOfFree
Combating Parkinson's disease-related movement disorder does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combating Parkinson's disease-related movement disorder, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combating Parkinson's disease-related movement disorder will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3617770